v3.25.4
SEGMENT INFORMATION - Segment Revenues and Profit (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Segment reporting information      
Revenues $ 5,101 $ 4,791 $ 4,146
Selling, general and administrative 2,234 2,082 1,736
Research and development 371 343 324
Operating income 113 162 130
Amortization of intangible assets (258) (288) (240)
Other expense, net (75) (44) (74)
Interest income 12 15 15
Interest expense (421) (399) (283)
Loss on extinguishment of debt (6) 0 0
Foreign exchange and other (15) (12) (28)
Loss before provision for income taxes (317) (234) (166)
Product Sales      
Segment reporting information      
Revenues 5,080 4,774 4,131
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 2,045 1,868 1,640
Cost of other revenues      
Segment reporting information      
Revenues 21 17 15
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 5 4 2
Vision Care      
Segment reporting information      
Revenues 2,923 2,739 2,543
Pharmaceuticals      
Segment reporting information      
Revenues 1,284 1,209 836
Surgical      
Segment reporting information      
Revenues 894 843 767
Operating Segment      
Segment reporting information      
Revenues 5,101 4,791 4,146
Selling, general and administrative
Research and development
Operating income 1,125 1,108 980
Operating Segment | Product Sales      
Segment reporting information      
Revenues 5,080 4,774 4,131
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues
Operating Segment | Cost of other revenues      
Segment reporting information      
Revenues 21 17 15
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues
Operating Segment | Vision Care      
Segment reporting information      
Revenues 2,923 2,739 2,543
Selling, general and administrative 912 882 832
Research and development 48 46 67
Operating income 849 808 689
Operating Segment | Vision Care | Product Sales      
Segment reporting information      
Revenues 2,914 2,731 2,535
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 1,113 1,002 954
Operating Segment | Vision Care | Cost of other revenues      
Segment reporting information      
Revenues 9 8 8
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 1 1 1
Operating Segment | Pharmaceuticals      
Segment reporting information      
Revenues 1,284 1,209 836
Selling, general and administrative 572 543 322
Research and development 53 33 20
Operating income 258 256 241
Operating Segment | Pharmaceuticals | Product Sales      
Segment reporting information      
Revenues 1,277 1,206 834
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 397 374 252
Operating Segment | Pharmaceuticals | Cost of other revenues      
Segment reporting information      
Revenues 7 3 2
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 4 3 1
Operating Segment | Surgical      
Segment reporting information      
Revenues 894 843 767
Selling, general and administrative 298 265 248
Research and development 43 42 35
Operating income 18 44 50
Operating Segment | Surgical | Product Sales      
Segment reporting information      
Revenues 889 837 762
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 535 492 434
Operating Segment | Surgical | Cost of other revenues      
Segment reporting information      
Revenues 5 6 5
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 0 0 0
Corporate      
Segment reporting information      
Operating income $ (679) $ (614) $ (536)